weight-loss-clinic-cv

ED J. HENDRICKS, M.D.

Education

B.A. Rice University, Houston, Texas
M.D. College of Physicians & Surgeons, Columbia University, New York City

Postgraduate Training

Internal Medicine, University of Texas Southwestern Medical School & Parkland Hospital, Dallas, Texas
Clinical and Anatomical Pathology, University of Minnesota Medical School & Hospital, Minneapolis, Minnesota

Honors

Full Tuition Scholarship, Rice University
Phi Beta Kappa, Rice University
Dean’s Scholarship, College of Physicians & Surgeons, Columbia University
NIH Fellowship, University of Minnesota
Bariatric Physician of the Year, 2009, American Society of Bariatric Physicians
Fellow, American Society of Bariatric Physicians, 2010
Vernon B. Astler Award, American Society of Bariatric Physicians, 2011

Board Certifications

American Board of Obesity Medicine, (formerly Amer. Board Bariatric Medicine)
American Board of Pathology, Clinical & Anatomic Pathology

Medical Licensure

California

Experience

Pathologist, U.S. Air Force Hospital, Anchorage, Alaska, 1966-1969
Associate Pathologist, St. Joseph Hospital, Houston, Texas, 1969-1972
Chief Pathologist & Laboratory Director, Fresno Community Hospital, Fresno, California, 1972-1986
Private Pathology Practice, Fresno, California, 1986-1988
Associate Pathologist, Mercy San Juan & Mercy Folsom Hospitals, Carmichael & Folsom, California, 1988-1989
Medical Director, Center for Weight Management, Roseville & Sacramento California, 1989 – Present

Of Note

Chairman, Board of Directors, Obesity Treatment Foundation 2012 –

Ex-Officio Trustee, Board of Directors, American Society of Bariatric Physicians, 2011- 2013
Trustee, Board of Directors, American Society of Bariatric Physicians, 2008 – 2010
Trustee, Board of Directors, American Board of Bariatric Medicine, 2000 – 2007
Secretary-Treasurer, American Board of Bariatric Medicine, 2002 – 2007
FDA Endocrine and Metabolic Drug Advisory Committee, 2010, 2011, 2012-2015

Memberships

Fellow, American Society of Bariatric Physicians (ASBP)
The Obesity Society (TOS, aka North American Society for the Study of Obesity)
Fellow, College of American Pathologists (inactive)
Fellow, American Society of Clinical Pathologists (inactive)
California Society of Pathologists (inactive)

Hospital Medical Staff Memberships (all past)

U.S.A.F. Hospital Elmendorf, Anchorage
St. Joseph Hospital, Houston
Fresno Community Hospital, Fresno
Clovis Community Hospital, Clovis
Veterans Administration Hospital Consultant, Fresno
Tulare County Hospital, Visalia
Mercy San Juan Hospital, Carmichael
Mercy Folsom Hospital, Folsom
Roseville Hospital, Roseville

Continuing Medical Education (recent only)

Obesity Society Annual Scientific Meeting, San Antonio, 2012
American Society of Bariatric Physicians Annual Seminar, Orlando, 2012
American Society of Bariatric Physicians and Metabolism Society, Denver, 2012
Obesity Society Annual Scientific Meeting, Orlando, 2011
American Society of Bariatric Physicians Annual Seminar, Las Vegas, 2011
Obesity Society Annual Scientific Meeting, San Diego, CA 2010
American Society of Bariatric Physicians Annual Seminar, New Orleans, 2010
Obesity Society Annual Scientific Meeting, Washington, DC, 2009
American Society of Bariatric Physicians Annual Seminar, Costa Mesa, 2009
American Society of Bariatric Physicians and Metabolism Society, Charleston, 2009
American Society of Bariatric Physicians Annual Seminar, Tampa, 2008
Obesity Society (NAASO), Annual Scientific Meeting, Phoenix, 2008
American Society of Bariatric Physicians Spring Meeting, Phoenix, 2008
American Society of Bariatric Physicians Annual Seminar, Las Vegas, 2007
Obesity Society (NAASO), Annual Scientific Meeting, New Orleans, 2007
American Society of Bariatric Physicians Spring Meeting, Nashville, 2007
American Board of Bariatric Medicine, Annual Review Course, Nashville, 2007
American Society of Bariatric Physicians Annual Seminar, San Diego, 2006
Obesity Society (NAASO), Annual Scientific Meeting, Boston, 2006
American Society of Bariatric Physicians Spring Meeting, Louisville, 2006
American Board of Bariatric Medicine, Annual Review Course, Louisville, 2006
American Society of Bariatric Physicians Annual Seminar, Las Vegas, 2005
Obesity Society (NAASO), Annual Scientific Meeting, Vancouver, B.C., 2005
American Society of Bariatric Physicians Spring Meeting, Atlanta, 2005
American Board of Bariatric Medicine, Annual Review Course, Atlanta, 2005
Obesity Society (NAASO), Annual Scientific Meeting, Las Vegas, 2004
American Society of Bariatric Physicians Spring Meeting, Scottsdale, 2004
American Society of Bariatric Physicians Annual Seminar, Chicago, 2003
American Society of Bariatric Physicians Spring Meeting, Las Vegas, 2003

Papers Published or Presented

1. Hendricks, E.J. Trends in U.S.A. Obesity Treatment. in Panbesy Asian Conference Tour (Eurodrug Laboratories, Chinese University of Hong Kong Medical School, , 2012, March 9).
2. Hendricks, E.J. Treatment of Obesity in the post-Sibutramine Era. What Are the Options? in Panbesy Asia Conference Tour (Eurodrug Laboratories, Seoul, Korea, 2012, March 7&8).
3. Hendricks, E.J. Treatment of Obesity in the post-SIbutramine Era. What are the Options? in Panbesy Asia Conference Tour (Eurodrug Laboratories, Singapore, 2012, March 3).
4. Schmidt, S.L. & Hendricks, E.J. The Use of Pharmacotherapy for Obesity Treatment in the United States. in 62nd Annual Obesity and Related Disorders Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).
5. Hendricks, E.J. & Rothman, R.B. Phentermine therapy for obesity does not elevate blood pressure. Diabetes, Obesity and Metabolism 13, 963-964 (2012).
6. Hendricks, E.J., Greenway, F., Srisurapanont, M., Hendricks, M.J. & De Marco, D. Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Amphetamine-like Phentermine Dependence, Cravings, or Withdrawal. in 62nd Annual Obesity and Related Disorders Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).
7. Hendricks, E.J., Greenway, F., Srisurapanont, M., DeMarco, D. & Hendricks, M.J. Long-term Phentermine Does Not Induce Amphetamine-like Dependence. in 62nd Annual Obesity and Related Diseases Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).
8. Hendricks, E.J., Greenway, F., Srisurapanont, M., De Marco, D. & Hendricks, M.J. Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal. in NCT01402674 (ed. Clinicaltrials.gov) (Center for Weight Management, Sacramento, 2012).
9. Hendricks, E.J. Using Phentermine, Topiramate, & Qsymia. in 62nd Annual Obesity and Related Disorders Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).
10. Hendricks, E.J. Two Addiction Medicine Studies in Patients treated with phentermine long-term in 62nd Annual Obesity and Related Conditions Symposium of the American Society of Bariatric Physicians (ASBP, Orlando, 2012).
11. Hendricks, E.J. Cardiovascular Outcomes Trials for New Obesity Drugs. in 62nd Annual Obesity and Related Conditions Symposium of the American Society Bariatric Physicians (ed. ASBP) (Orlando, 2012).
12. Hendricks, E.J. Letter by Hendricks Regarding Article, “Obesity and Cardiovascular Disease”. Circulation 126, e191 (2012).
13. Hendricks, E.J. & Rothman, R.B. RE: Pulmonary Hypertension Associated with Use of Phentermine? Yonsei Med J 52, 869-870 (2011).
14. Hendricks, E.J. & Rothman, R.B. The Case of Posterior Reversible Encephalopathy with Intracranial Hemorrhage Was Likely Due to Uncontrolled Hypertension, And Was Unrelated and Coincidental to Long-term Phentermine Use. Neurologist Manuscript NRL-11-61 under editorial review(2011).
15. Hendricks, E.J., Greenway, F.L., Westman, E.C. & Gupta, A.K. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obesity (Silver Spring) 19, 2351-2360 (2011).
16. Hendricks, E.J. & Greenway, F.L. A Study of Abrupt Phentermine Cessation in Patients in a Weight Management Program. American Journal of Therapeutics 18, 292-299 (2011).
17. Hendricks, E.J. Should the FDA approval process for weight-loss drugs be modified? Am J Health Syst Pharm 68, 2094-2095 (2011).
18. Hendricks, E.J. Rhabdomyolysis and phentermine: Coincidence, not causation. Am J Health Syst Pharm 68, 1386-1395 (2011).
19. Rothman, R.B. & Hendricks, E.J. Phentermine cardiovascular safety. In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3. Int J Cardiol 144, 241-242; author reply 242-243 (2010).
20. Rothman, R.B. & Hendricks, E.J. Phentermine cardiovascular safety II: Response to Yosefy Int J Cardiol. 2009 Epub Mar 19. Int J Cardiol (2010).
21. Hendricks, E.J., Greenway, F., Westman, E. & Gupta, A.K. Phentermine pharmacotherapy for Weight Management in Overweight to Morbidly Obese Subjects does not alter seated resting office blood pressure 475P Obesity 18, S2, S151 (2010).
22. Hendricks, E.J. Long-term Phentermine: Weight Loss, Blood Pressure, & Heart Rate Effects. in American Society Bariatric Physicians 60th Annual Obesity Seminar (New Orleans, 2010).
23. Hendricks, E.J. Chapter 8: Pharmcotherapy. in Obesity: Evaluation and Treatment Essentials (eds. Steelman, G.M. & Westman, E.) 81-99 (Informa Healthcare, New York, New York, 2010).
24. Rothman, R.B. & Hendricks, E.J. Phentermine Cardiovascular Safety. American Journal of Emergency Medicine 27, 1010-1013 (2009).
25. Hendricks, E.J., Rothman, R.B. & Greenway, F.L. How Physician Obesity Specialists Use Drugs to Treat Obesity. Obesity 17, 1730-1735 (2009).
26. Hendricks, E.J. & Greenway, F.L. Symptoms Observed after Abrupt Phentermine Cessation 223-P. Obesity 17, S111 (2009).
27. Hendricks, E.J. & Greenway, F.L. Symptoms Observed after Abrupt Phentermine Cessation. in 27th Annual Scientific Meeting (The Obesity Society, Washington, D.C., 2009).
28. Hendricks, E.J. Is Phentermine Addicting? in 59th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Costa Mesa, 2009).
29. Hendricks, E.J. & Westman, E.C. Phentermine Therapy in Obesity Treatment: Effect on Blood Pressure 582P. Obesity 16, Supplement 1, S216 (2008).
30. Hendricks, E.J., et al. A Survey of Prescribing Practices of Medical Bariatricians. Obesity 16, S292-293 (2008).
31. Hendricks, E.J. Adverse Reactions to Phentermine, Evidence versus Conjecture. in 58th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Tampa, FL, 2008).
32. Hendricks, E.J. ASBP Membership Survey of Prescribing Practices. in 58th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Tampa, Florida, 2008).
33. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (Nashville, TN, 2007).
34. Hendricks, E.J. “Indications for Phentermine Use in Treating Obesity: Re-examination of Current Guidelines”. in Eastern Regional Obesity Course, American Society of Bariatric Physicians (Nashville, TN, 2007).
35. Hendricks, E.J. “Using the Web to Stay Current with Obesity Treatment and Research”. in 56th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, San Diego, CA, 2006).
36. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (American Board of Bariatric Medicine, Lexington, KY, 2006).
37. Hendricks, E.J. Weight Control Pharmacology in Bariatric Surgical Practice. in Bariatric Times, Vol. 3 1,16-19 (2006).
38. Hendricks, E.J., Bryman, D. A., Roldan, E. O. Insurance Panel Debate: Pros and Cons. in 55th Annual Obesity & Associated Conditions Symposium (American Society of Bariatric Physicians, Las Vegas, 2005).
39. Hendricks, E.J. “New Obesity Drugs: Current Status Report”. in Eastern Regional Obesity Course, American Society of Bariatric Physicians (Atlanta, GA, 2005).
40. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (American Board of Bariatric Medicine, Atlanta, GA, 2005).
41. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (Scottsdale, AZ, 2004).
42. Hendricks, E.J. “Pathophysiology of Obesity”. in Annual Review Course, American Board of Bariatric Medicine (Scottsdale, AZ, 2004).
43. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board Bariatric Medicine (Las Vegas, NV., 2003).
44. Hendricks, E.J. “New Bariatric Drugs”. in Western Regional Obesity Course, American Society Bariatric Physicians (Las Vegas, NV, 2003).
45. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board Bariatric Medicine (Denver, CO, 2002).
46. Hendricks, E.J. “Pathophysiology of Obesity”. in Basic Bariatric Course, American Society Bariatric Physicians (Boston, MA, 2002).
47. Hendricks, E.J. New Drugs for Obesity: Drugs in Phase 2 Clinical Trials. American Journal Bariatric Medicine 17, 17- (2002).
48. Hendricks, E.J. New Drugs for Obesity: Drugs in Phase 1 Clinical Trials. American Journal Bariatric Medicine 17, 16- (2002).
49. Hendricks, E.J. “Pharmacotherapy of Obesity”. in Annual Review Course, American Board Bariatric Medicine (Atlanta, GA, 2001).
50. Hendricks, E.J. “New Drugs on the Horizon”. in 51st Annual Obesity & Associated Conditions Symposium, American Society Bariatric Physicians (San Diego, CA, 2001).
51. Hendricks, E.J. New Drugs for Obesity: Drugs in Phase 3 Clinical Trials. American Journal Bariatric Medicine 16, 15- (2001).
52. Hendricks, E.J. Laboratory computers: tools for increased productivity. Clin Lab Med 5, 709-723 (1985).
53. Chen, K.T. & Hendricks, E.J. Malakoplakia of the female genital tract. Obstet Gynecol 65, 84S-87S (1985).
54. Hendricks, E.J. & Langhofer, L.A. A community hospital laboratory computer system: an eight-year longitudinal study of economic impact. Am J Clin Pathol 77, 297-304 (1982).
55. Chen, K.T., Hendricks, E.J. & Freeburg, B. Benign glandular inclusion of the peritoneum associated with leiomyomatosis peritonealis disseminata. Diagn Gynecol Obstet 4, 41-44 (1982).
56. Hendricks, E.J. “The Computerized Laboratory of the Future”. in Symposium on Clinical Decision Making and Laboratory Use, Riyadh-Al-Karj Hospital (Riyadh, Saudi Arabia, 1981).
57. Chen, K.T., Hoffman, K.D. & Hendricks, E.J. Angiosarcoma following therapeutic irradiation. Cancer 44, 2044-2048 (1979).
58. Hendricks, E.J. “Mechanisms of Subspecialty Training: Where -University or Private Hospital”. in Symposium on the Future of Graduate Medical Education in Pathology, American Society Clinical Pathologists (Monterey, CA, 1976).
59. Hendricks, E.J. “How Should the Pathologist be Trained to Fulfill His Clinical Role?”. in Symposium on the Future of Graduate Medical Education in Pathology, American Society Clinical Pathologists (Monterey, CA, 1976).
60. Simon, R.G., Langhofer, L.A., Jr. & Hendricks, E.J. Australia Antigen Content of Commercial Quality-Control Sera. Clin Chem 19, 221-222 (1973).
61. Hendricks, E.J. “Use of Amniotic Fluid Analysis in Prenatal Management of Rh Disease”. in Annual Meeting, Texas Medical Association (Houston, Texas, 1972).
62. Hendricks, E.J. Quality control in transition; use of computers in the laboratory. Postgrad Med 44, 67-69 (1968).
63. Hendricks, E.J. Methods of blood glucose determination. Postgrad Med 42, A46 passim (1967).
64. Hendricks, E. Laboratory Tests of Anterior Pituitary Function. Postgrad Med 37, A44-52 (1965).

Research in Progress

1. Hendricks, E.J., Greenway, F., Srisurapanont, M., De Marco, D. & Hendricks, M.J. Long-term Phentermine Pharmacotherapy: An Investigation for Symptoms of Dependence, Cravings, or Withdrawal. NCT01402674 at Clinicaltrials.gov; An investigation in progress at Center for Weight Management, Sacramento, 2012.
2. Hendricks, E.J., Greenway, F., Srisurapanont, M., Hendricks, M.J. & De Marco, D. Psychometric Scale Addiction Metrics During Long-term Phentermine Treatment for Obesity. An investigation in progress at Center for Weight Management, Sacramento, 2012.

Schedule A Consultation

Three months from today, you'll be glad you made the decision to start!

  • Hendricks Shop

    Our clinical and nutrition experts have already vetted products for maximum effectiveness and taste.
    Go to Shop
  • Patient Stories

    For over twenty years, we have served thousands of patients. Let some of your peers share with you their stories of triumph and lives transformed.
    Read more
  • Roseville Office

    Closed for lunch every day between 1:00-2:00 pm.

    • Monday
      9:00 am - 4:30pm
    • Tuesday
      9:00 am - 5:00pm
    • Wednesday
      9:00 am - 5:00pm
    • Thursday
      9:00 am - 5:30pm
    • Friday
      9:00 am - 5:00pm
    • Saturday
      9:00 am - 4:30pm
  • Sacramento Office

    Closed for lunch every day between
    1:00-2:00pm.

    • Tuesday
      9:00 am - 5:00pm
    • Thursday
      9:00 am - 5:00pm
    • Friday
      9:00 am - 4:00pm
      Lunch 1-1:30pm